Going Public When You Can in Biotechnology
收藏数据链接：
官方服务：
资源简介：
Scientist-entrepreneurs prominent in biotech and other high-technology industries view going public not as a cost-effective source of capital but as a cross between selling a now-proven innovation and winning a lottery. Unlike most empirical IPO analyses confined to those firms that go public, we
提供机构：
美国国家经济研究局创建时间：
2002-05-01
